Ridinilazole

DB15308InvestigationalSmall molecule

Ridinilazole is under investigation in clinical trial NCT02092935 (A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)).

Formula / weight: C₂₄H₁₆N₆ · 388.434 g/mol (avg)
Code names: SMT19969

Resolves to

Compound

UNII06DX01190RCAS308362-25-6ChEMBLCHEMBL3753858

Structure

InChIKeyUHQFBTAJFNVZIV-UHFFFAOYSA-NSMILESN1C2=CC(=CC=C2N=C1C1=CC=NC=C1)C1=CC2=C(C=C1)N=C(N2)C1=CC=NC=C1

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Ridinilazole, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account